UK MHRA Makes Statements On Brexit Implementation Period – But On Shaky Ground?
Executive Summary
The UK and EU27 medtech industries are desperate for information about what to do to prepare for Brexit. The UK medtech regulator has issued documents that might give insight, but there are still no certainties on the horizon.
You may also be interested in...
UK Medtechs' Brexit Readiness Moves Up A Notch In Absence Of EU Deal Framework
The UK is unmistakeably in the period of the calm before the storm, and an enforced Brexit lull is in place. But the thoughts of UK and EU decision-makers – and UK medtech companies – are not straying too far from the upcoming trade deal negotiations and the business of making the best of Brexit, however and whenever it manifests itself.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.